Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
White Noise and Questions Regarding Death Anxiety, Forgiveness, and Patient Self-disclosure

By |September 1, 2023|Comments Off on White Noise and Questions Regarding Death Anxiety, Forgiveness, and Patient Self-disclosure

by Edmund Howe III, MD, JD  Dr. Howe is Professor of Psychiatry, Uniformed Services University of the Health Sciences in Bethesda, Maryland. Funding: No funding was provided for this article. Disclosures: The authors have no [...]

Role of Parenting and Psychosocial Correlates Contributing to Social Anxiety in Asian Adolescents: A Systematic Review

By |September 1, 2023|Comments Off on Role of Parenting and Psychosocial Correlates Contributing to Social Anxiety in Asian Adolescents: A Systematic Review

by Uzma Ilyas, PhD scholar, and Prof. Dr. Saima Dawood Khan,PhD Ms. Ilyas is PhD Scholar, Centre for Clinical Psychology, University of the Punjab in Lahore, Pakistan, and Principal Lecturer, Psychology Department, University of Central [...]

Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report

By |September 1, 2023|Comments Off on Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report

by David Wyndham Lawrence, MD, MPH  Dr. Lawrence is with the Faculty of Medicine, University of Toronto in Toronto, Canada; Mount Sinai Hospital, Sinai Health System in Toronto, Canada; and Faculty of Kinesiology & Physical [...]

Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness

By |September 1, 2023|Comments Off on Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness

by Jacqueline Lutz, PhD; Abhishek Pratap, PhD; Eric J. Lenze, MD; Durga Bestha, MD; Jessica M. Lipschitz, PhD; Stella Karantzoulis, PhD; Uma Vaidyanathan, PhD; Jessica Robin, PhD; William Horan, PhD; Stephen Brannan, MD; Aurelia Mittoux, [...]

Exploring the Complex Relationship Between Antiepileptic Drugs and Suicidality: A Systematic Literature Review

By |September 1, 2023|Comments Off on Exploring the Complex Relationship Between Antiepileptic Drugs and Suicidality: A Systematic Literature Review

by Aksha M. Memon, MBBS, MD, MPH; Jigar Katwala, MBBS, MD; Clarice Douille, BS; Caitlin Kelley, BS; and  Varun Monga, MD Dr. Memon is with Creighton University School of Medicine in Phoenix, Arizona. Mses. Douille [...]

Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis

By |December 1, 2022|Comments Off on Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis

Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(10–12):8–9. Dear Editor: Patients exposed to [...]

Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis

By |December 1, 2022|Comments Off on Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis

by Atmaram Yarlagadda, MD; Adrian R. Johnson, LCSW, MSW; Cheyenne M. Bickerstaff, BS; Joseph R. Yancey, MD, MBA; Samuel L. Preston, DO; Liquori L. Etheridge, LCSW; Michelle Maddalozzo, LCSW; Samuel Ochinang, LCSW; Rosemary A. Jackson, DNP, PMHNP-BC; and [...]

Past Articles
Letter to the Editor: Responding to commentary: addressing points raised in the correspondence about “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter. Dear Editor: It was with [...]

Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a consultant for AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune [...]

Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is co-author and intellectual property owner of the EPICOG-SCH battery. No funding was received for the preparation of this letter. Dear Editor: As co-author of the [...]